missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CD177 Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (49%), Rat (49%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
CD177 (NB1/HNA-2a and PRV-1 form) is a GPI-anchored glycoprotein present mainly on neutrophils. Its plasma membrane expression is increased during pregnancy and and inflammation or after G-CSF application. Ligand of CD177 has been identified as CD31 (PECAM-1). CD177 participates in neutrophil transmigration and seems to be also a pro-proliferative molecule. The antibodies against CD177 can be involved in neonatal alloimmune neutropenia (NAN).

Specifications
Specifications
Accession Number | Q8N6Q3 |
Concentration | ≥5.0 mg/mL |
For Use With (Application) | Blocking Assay, Control |
Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
Gene ID (Entrez) | 57126 |
Name | Human CD177 Control Fragment |
Quantity | 100 μL |
Regulatory Status | RUO |
Gene Alias | 1190003K14Rik; CD177; CD177 antigen; CD177 molecule; cell surface receptor; HNA2A; HNA-2 A; Human neutrophil alloantigen 2 A; NB1; NB1 glycoprotein; NB1 GP; Pdp3; Polycythemia rubra vera protein 1; PRV1; PRV-1; RGD1562941; UNQ595/PRO1181 |
Common Name | CD177 |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human CD177 Control Fragment Recombinant Protein >
Spot an opportunity for improvement?Share a Content Correction